Dunn FW - Search Results

1

In vivo effect of ticlopidine on fibrinogen-platelet cofactor activity and binding of fibrinogen to platelets.

Dunn FW, Soria J, Soria C, Thomaidis A, Lee H, Caen JP. Dunn FW, et al. Agents Actions Suppl. 1984;15:97-104. doi: 10.1007/BF01966985. Agents Actions Suppl. 1984. PMID: 6091425 No abstract available.

2

Analogy between fibrinogen and casein. Effect of an undecapeptide isolated from kappa-casein on platelet function.

Jollès P, Lévy-Toledano S, Fiat AM, Soria C, Gillessen D, Thomaidis A, Dunn FW, Caen JP. Jollès P, et al. Among authors: dunn fw. Eur J Biochem. 1986 Jul 15;158(2):379-82. doi: 10.1111/j.1432-1033.1986.tb09764.x. Eur J Biochem. 1986. PMID: 3732274 Free article.

3

Interactions of platelets with standard heparin and low molecular weight fractions.

Dunn FW, Soria C, Thomaidis A, Soria J, Dupuy E, Bellucci S, Tobelem G. Dunn FW, et al. Nouv Rev Fr Hematol (1978). 1984;26(4):249-53. Nouv Rev Fr Hematol (1978). 1984. PMID: 6089103

4

Fibrinogen binding on human platelets. Influence of different heparins and of pentosane polysulfate.

Dunn F, Soria J, Soria C, Thomaidis A, Tobelem G, Caen JP. Dunn F, et al. Thromb Res. 1983 Jan 15;29(2):141-8. doi: 10.1016/0049-3848(83)90135-4. Thromb Res. 1983. PMID: 6189236

5

Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.

Niewiarowski S, Kornecki E, Hershock D, Tuszynski GP, Bennett JS, Soria C, Soria J, Dunn F, Pidard D, Kieffer N, et al. Niewiarowski S, et al. J Lab Clin Med. 1985 Dec;106(6):651-60. J Lab Clin Med. 1985. PMID: 2999274

6

The potentiating effect of platelet on plasminogen activation by tissue plasminogen activator.

Deguchi K, Murashima S, Shirakawa S, Soria C, Soria J, Dunn F, Tobelem G. Deguchi K, et al. Thromb Res. 1985 Dec 15;40(6):853-61. doi: 10.1016/0049-3848(85)90321-4. Thromb Res. 1985. PMID: 3937289

7

Importance of the interaction between plasminogen and fibrin for plasminogen activation by tissue-type plasminogen activator.

Dunn FW, Deguchi K, Soria J, Soria C, Lijnen HR, Tobelem G, Caen J. Dunn FW, et al. Thromb Res. 1984 Nov 15;36(4):345-51. doi: 10.1016/0049-3848(84)90326-8. Thromb Res. 1984. PMID: 6543039

8

Plasminogen Paris I: congenital abnormal plasminogen and its incidence in thrombosis.

Soria J, Soria C, Bertrand O, Dunn F, Drouet L, Caen JP. Soria J, et al. Thromb Res. 1983 Oct 15;32(2):229-38. doi: 10.1016/0049-3848(83)90034-8. Thromb Res. 1983. PMID: 6658714

9

The amidolytic activity of the SK-plasminogen complex is enhanced by a potentiator which is generated in the presence of vascular plasminogen activator--role of fibrin degradation products.

Soria J, Soria C, Bertrand O, Dunn F, Samama M, Bachmann F. Soria J, et al. Thromb Haemost. 1982 Jun 28;47(3):193-6. Thromb Haemost. 1982. PMID: 7051407

10

Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation.

Spinella-Jaegle S, Roman-Roman S, Faucheu C, Dunn FW, Kawai S, Galléa S, Stiot V, Blanchet AM, Courtois B, Baron R, Rawadi G. Spinella-Jaegle S, et al. Among authors: dunn fw. Bone. 2001 Oct;29(4):323-30. doi: 10.1016/s8756-3282(01)00580-4. Bone. 2001. PMID: 11595614

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters